Clinical Trial

Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata

Name: Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata — clinical trial record (NCT07757867)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

This study planned to measure the effectiveness and safety of microneedling aided administration of cetirizine 1% versus latanoprost 0.01% in alopecia areata.

Trial Details

NCT Number	NCT07757867
Lead Sponsor	Tanta University
Conditions	Microneedling-Assisted Delivery, Cetirizine, Latanoprost, Alopecia Areata
Enrollment	80 participants
Start Date	2022-10-01
Primary Completion	2024-10-01 (estimated)
Study Completion	2024-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-08-11